Replimune Group
REPL • NASDAQ
Replimune Group is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sushil Patel, with a market cap of $488.0M.
Market Cap$488.0M
Employees331.0
CEOSushil Patel
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 21, 2026 · in a monthQ4 2026
Financials
Replimune Group FAQ
Common questions about Replimune Group
Replimune Group is scheduled to report earnings for Q4 2026 on May 21, 2026. Analysts estimate revenue of $12.6M.
Replimune Group has approximately 331 employees.